SRTA (Strata Critical Medical Corp) Market Value to Book Value Ratio

Strata Critical Medical Corp (SRTA) - corporate logo

Global supply stability and the simplification of international certification are critical for the medtech provider Strata Critical Medical Inc (SRTA). This chart reflects the price action of the asset, which currently stands at 1.51. The business relies on express organ transport via helicopters to ensure maximum operational speed. High confidence among leading US hospitals in the reliability of such transport provides Strata Critical Medical Inc (SRTA) with exceptional professional loyalty.

Market Capitalization to Net Assets: Strata Medical (SRTA) for 07/04/2022 - 10/28/2026
Finished products of Blade Air Mobility

This indicator serves as a stress-testing tool for positions, allowing for the determination of the degree of deviation of the market value of Strata Critical Medical Inc (SRTA) from its actual book value. By analyzing changes in the level of balance sheet capital revaluation, the investor assesses the justification of quotes relative to assets, which is critical for a business dependent on aviation regulations and the willingness of medical centers to pay for premium organ logistics.

Direct competitors

BSX: Market Capitalization to Book Value Ratio|EW (edwards.com) - Market Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Carlsmed Inc (CARL) - Market Cap to Net Assets Ratio|Market Value to Book Value RXST (rxsight.com)|ClearPoint Neuro - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO